Mr Geoffrey G Penney, PHARMD in Biddeford, ME - Pharmacist

Mr Geoffrey G Penney, PHARMD is a Pharmacist based in Biddeford, Maine. Mr Geoffrey G Penney is licensed to practice in Maine (license number PR12940) and his current practice location is 384 Elm St, Biddeford, Maine. He can be reached at his office (for appointments etc.) via phone at (207) 282-3187.

NPI number for Mr Geoffrey G Penney is 1487125373 and his current mailing address is 384 Elm St, Biddeford, Maine. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1487125373.

Contact Information

	Mr Geoffrey G Penney, PHARMD
	384 Elm St, Biddeford, ME 04005-3012
	(207) 282-3187
	(207) 282-3514

Healthcare Provider's Profile

Full Name	Mr Geoffrey G Penney
Gender	Male
Speciality	Pharmacist
Location	384 Elm St, Biddeford, Maine
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1487125373
Provider Enumeration Date: 12/17/2018
Last Update Date: 12/17/2018

Medical Identifiers

Medical identifiers for Mr Geoffrey G Penney such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487125373	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PR12940 (Maine)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Geoffrey G Penney is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Geoffrey G Penney, PHARMD 384 Elm St, Biddeford, ME 04005-3012 Ph: (207) 282-3187	Mr Geoffrey G Penney, PHARMD 384 Elm St, Biddeford, ME 04005-3012 Ph: (207) 282-3187

News Archive

Phase 1/2 human clinical trial of Symphogen's Sym004 initiated in the US

Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.

Echo net loss for first half 2011 increases to $6.5 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude SkinPrep System for transdermal drug delivery, today announced results for the period ended June 30, 2011.

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.

AlerSense develops world's first smart airborne allergy and asthma early warning system

AlerSense Incorporated has created the world's first smart airborne allergy and asthma early warning system alerting consumers as particles and toxins build. AlerSense is an in-home unit when, combined with the mobile app, delivers accurate environmental readings, giving asthma and allergy sufferers precious time to remove themselves from, or alter the environment to possibly mitigate or avoid an allergy or asthma attack.

Achieve Nutrition Systems, Game Plan Holdings announce new partnership deal

Game Plan Holdings, Inc., a nutritional supplements company that distributes products both online and through a network of fitness professionals, announced today it entered a partnership deal with Achieve Nutrition Systems, a one-of-a-kind company serving businesses in the fitness, nutrition and therapeutic industries by offering a professional development network with revenue streams, systems and coaching to business owners who want to take their business and professionalism the next level.

Pharmacist in Biddeford, ME

Whitney Boudreau Holmes, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 299 Elm St, Biddeford, ME 04005 Phone: 207-283-0409 Fax: 207-282-8341
Mrs. Lori Ann Mckeown, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Boulder Way, Biddeford, ME 04005 Phone: 207-286-9562 Fax: 207-286-9576
Dr. Aaron T Dionne, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 299 Elm St, Biddeford, ME 04005 Phone: 207-283-0409 Fax: 207-282-8341
Mr. Fernand J Bernier, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7222 Fax: 207-283-7879
Mary Elizabeth Broadhead, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 430 Mariner Way, Biddeford, ME 04005 Phone: 207-284-2511 Fax: 207-284-2516
Richard Earle Bowman Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7875
Victoria Chase, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 384 Elm St, Biddeford, ME 04005 Phone: 207-282-3187

Mr Geoffrey G Penney, PHARMD - Pharmacist in Biddeford, ME